TGA rules out over-the-counter sales of oral contraceptives The RACGP has consistently opposed any efforts to down-schedule the pill, citing patient safety.
How important is Pfizer’s new COVID-19 antiviral likely to be? The US pharmaceutical company has said clinical trial results of its new COVID-19 pill are ‘game-changing’. Experts give newsGP their take on its likely impact.
Contraceptive pill to remain prescription only – at least for now The TGA is not due to make a final ruling until later this year, but GPs fear the implications if the interim decision is overturned.
Australia secures 300,000 courses of COVID antiviral The supply agreement could mean molnupiravir is being used to treat COVID-19 by early 2022, provided it is approved by the TGA.
Combined oral contraceptive pill In this episode, the Good GP interviews Dr Karin Sekhon on what to discuss during the consultation, how the pill works, the different pills and deciding which one to prescribe.
How did the college advocate for members last month? The Federal Budget, pharmacy prescribing and new dedicated MBS item numbers for smoking cessation all elicited an RACGP response.
‘Unsafe and unnecessary’: RACGP opposes down-scheduling of the pill The college has said the ‘doubtful benefits’ of removing the need for a GP prescription do not outweigh the risks.
Potential COVID treatment reduces viral count in mice lungs by 99.9% And experts believe this form of medicine will translate to similar outcomes in humans, making it a ‘viable therapy’ for COVID-19.
Early use of antivirals ‘significantly’ affects flu outcomes: Study While there was no effect on mortality at 30 days, this measure reduced length of hospital stay and readmission rates.
Is Australia at risk of a rebound flu season? Social distancing measures and high vaccination rates have contributed to record low cases of influenza, but it could also have implications for 2021.